Jon Congleton, CEO: Mineralys Therapeutics MLYS Sell · Filed 10/02

Trade details

Type: Insider sale
Amount: $1,909,665
Shares · price: 75,000 sh · $25.46 a share
Held after: 528,621 sh
Stock: Mineralys Therapeutics MLYS
Person: Jon CongletonCEO
Trade date: 26/09/30
Filed: 26/10/02
Days to filing: 2 days

Sold 12.4% of holdings

Share of holding sold: 12.4%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 08/31~10/30

Jon Congleton's recent trades

Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$1.9M
75,000 sh
$1.9M
Filed 09/30
Traded 09/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$291.4K
10,700 sh
$291.4K
Filed 07/13
Traded 07/13
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$1.5M
58,000 sh
$1.5M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$455.9K
17,000 sh
$455.9K
Filed 06/30
Traded 06/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2M
75,000 sh
$2M
Filed 06/30
Traded 06/30